High risk HPV persists after treatment of genital papillomavirus infection but not after treatment of cervical intraepithelial neoplasia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 76, Issue 2, 1997, Pages 140-144

  Strand, Anders ^a   Wilander, Eric ^a   Zehbe, Ingeborg ^a   Rylander, Eva ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Acuminate and papular lesions; Cervical intra epithelial neoplasia (CIN); Condylomata acuminata; Detection methods; Genital infection; Human papillomavirus infection (HPV); Hybridization; Viral persistence

Indexed keywords

PODOPHYLLOTOXIN; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENITAL TRACT INFECTION; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

EID: 0031050602     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349709050070     Document Type: Article

References (25)

1. Meyers C, Frattini MG, Hudson JB, Laimins LA. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992; 257: 971-3.
2. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the transmission of genital herpes. Ann Intern Med 1992; 116: 197-202.
3. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333: 770-5.
4. Strand A, Rylander E, Evander M, Wadell G. Genital human papillomavirus infection among patients attending an STD clinic. Genitourin Med 1993; 69: 446-9.
5. Karlsson R, Johansson M, Edlund K et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population based study. Sex Transm Dis 1995; 22: 119-27.
6. Bavin PJ, Giles JA, Derry A et al. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with mild dyskaryotic smear report. Br J Cancer 1993; 67: 602-5.
7. Cox JT, Lorincz AT, Schiffamn MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172: 946-54.
8. Strand A, Brinkeborn RM, Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin Med 1995; 71: 387-90.
9. Lungo O, Jr Wright TC, Silverstein S. Typing of human papillomavirus by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 1992; 6: 145-52.
10. Saiki RK, Scarf S, Faloona F et al. Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-4.
11. Chua KL, Hjerpe A. Polymerase chain reaction (PCR) analysis of human papillomavirus (HPV) in archival Pap smears. Analyt Quant Histol 1995; 17: 221-9.
12. de Roda Husman A-M, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057-62.
13. Erlich HA, Gelfand D, Sninsky JJ. Recent advances in the polymerase chain reaction. Science 1991; 252: 1643-56.
14. Gissman L, Wolnik L, Ikenberg H et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proceedings of the National Academy of Sciences of the USA 1983; 80: 560-3.
15. Bauer HM, Hildesheim A, Schiffman MH et al. Determinants of genital papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993; 20: 274-8.
16. Voog E, Bolmstedt A, Olofsson S, Ryd W, Löwhagen G-B. Human papillomavirus infection among women attending an STD clinic correlated to reason for attending, presence of clinical signs, concomitant infections and abnormal cytology. Acta Derm Venereol 1995; 75: 75-8.
17. Koutsky LA, Holmes KK, Critchlow CW et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 1272-8.
18. Bekassy Z, Ahlgren M, Eriksson M, Lindh E. Carbon dioxide laser miniconization for treatment of human papillomavirus infection associated with cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1995; 74: 822-6.
19. Elfgren K, Bistoletti P, Dillner L, Walboomers JMM, Meijer CJLM, Dillner J. Conization of CIN is followed by a disappearance of HPV DNA and a decline of serum and cervical mucus antibodies against HPV antigens. Am J Obstet Gynecol 1996; 174: 937-42.
20. Wikström A, van Doornum GJ, Quint WG, Schiller JT, Dillner J. Identification of human papillomavirus seroconversions. J Gen Virol 1995; 76: 529-39.
21. Benton C, Shahidullah H, Hunter J. Human papillomavirus in immunosuppressed. Papillomavirus Rep 1992; 3: 23-36.
22. Schneider A, Kirchmayr R, Villiers E-MD, Gissmann L. Subclinical human papillomavirus infection in male partners of female carriers. J Urol 1988; 140: 1431-4.
23. Gath DH, Hallam N, Mynors-Wallis L, Day A, Bond SAK. Emotional reactions in women attending a UK colposcopic clinic. J Epidemiol Community Health 1995; 49: 79-83.
24. Macgregor JE, Campbell MK, Mann EMF, Swanson KY. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ 1994; 308: 3104-9.
25. Remmink AJ, Walboomers JMM, Heimerhorst TJM et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995; 61: 306-11.